Clinical Roundup Tiragolumab + atezolizumab for metastatic nSq NSCLC did not meet primary endpoints in phase II/III trial July 12, 2024Vol.50 No.28
Clinical Roundup Chemotherapy disrupts gut microbiome in patients with breast cancer July 12, 2024Vol.50 No.28
Clinical Roundup Survivorship standards help address the distinct needs of adult cancer survivors July 12, 2024Vol.50 No.28
Clinical Roundup Novel Co-STAR receptor shows promise treating cancers in preclinical study July 12, 2024Vol.50 No.28
Clinical Roundup Exscientia builds AWS AI-powered platform to advance drug discovery July 12, 2024Vol.50 No.28
Clinical Roundup Changing gut microbiome improves outcomes for people newly diagnosed with metastatic kidney cancer in phase I study July 05, 2024Vol.50 No.27
Clinical Roundup FDA guidance provides new details on diversity action plans for clinical studies June 28, 2024Vol.50 No.26
Clinical Roundup Upregulating TERT gene expression reverses multiple hallmarks of aging June 28, 2024Vol.50 No.26
Clinical Roundup CHK1 inhibitor + rheumatoid arthritis drug could be therapy for NSCLC June 28, 2024Vol.50 No.26
